Illumina Body Map 2
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MYOG | hg19_v2_chr1_-_203055129_203055164 | 0.30 | 9.2e-02 | Click! |
TCF3 | hg19_v2_chr19_-_1652575_1652621 | -0.03 | 8.7e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr9_-_35689900 Show fit | 13.70 |
ENST00000378300.5
ENST00000329305.2 ENST00000360958.2 |
tropomyosin 2 (beta) |
|
chr19_-_45826125 Show fit | 12.92 |
ENST00000221476.3
|
creatine kinase, muscle |
|
chr2_+_220283091 Show fit | 9.94 |
ENST00000373960.3
|
desmin |
|
chr4_+_114214125 Show fit | 8.41 |
ENST00000509550.1
|
ankyrin 2, neuronal |
|
chr3_-_195310802 Show fit | 8.27 |
ENST00000421243.1
ENST00000453131.1 |
apolipoprotein D |
|
chr8_-_33455268 Show fit | 7.95 |
ENST00000522982.1
|
dual specificity phosphatase 26 (putative) |
|
chr22_+_31489344 Show fit | 7.90 |
ENST00000404574.1
|
smoothelin |
|
chr4_+_113970772 Show fit | 7.40 |
ENST00000504454.1
ENST00000394537.3 ENST00000357077.4 ENST00000264366.6 |
ankyrin 2, neuronal |
|
chr1_+_78354330 Show fit | 7.36 |
ENST00000440324.1
|
nexilin (F actin binding protein) |
|
chr2_-_152590946 Show fit | 7.34 |
ENST00000172853.10
|
nebulin |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 64.8 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
1.2 | 31.7 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
1.3 | 19.0 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.1 | 18.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
3.2 | 15.8 | GO:0036371 | protein localization to T-tubule(GO:0036371) |
1.4 | 15.7 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 15.4 | GO:0006936 | muscle contraction(GO:0006936) |
0.9 | 13.3 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.6 | 12.8 | GO:0045475 | locomotor rhythm(GO:0045475) |
3.2 | 12.6 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 86.3 | GO:0030018 | Z disc(GO:0030018) |
0.7 | 40.4 | GO:0031430 | M band(GO:0031430) |
1.0 | 33.3 | GO:0005865 | striated muscle thin filament(GO:0005865) |
1.2 | 27.8 | GO:0005861 | troponin complex(GO:0005861) |
0.8 | 21.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.4 | 17.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 16.0 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 15.7 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
1.7 | 13.3 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 13.3 | GO:0005901 | caveola(GO:0005901) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 112.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 19.1 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
1.8 | 18.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.3 | 17.0 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 17.0 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.8 | 15.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 14.0 | GO:0003779 | actin binding(GO:0003779) |
0.4 | 13.1 | GO:0043495 | protein anchor(GO:0043495) |
3.2 | 12.6 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.2 | 12.2 | GO:0030332 | cyclin binding(GO:0030332) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 33.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 14.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 11.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 10.1 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 8.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.3 | 8.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 8.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 7.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 7.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 7.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 64.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.7 | 35.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.4 | 12.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.4 | 10.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 10.7 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 10.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.3 | 10.0 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 9.7 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 8.7 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.2 | 8.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |